🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementNausea incidence by dose tier — my results so far

Nausea incidence by dose tier — my results so far

MikeFit_NJ Fri, Apr 26, 2024 at 7:15 AM 52 replies 2,374 viewsPage 1 of 11
This thread is more than 22 months old. Information may be outdated. Consider searching for more recent discussions.
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Apr 26, 2024 at 8:40 AM#1

I've been on semaglutide since September and the titration up to 1.0mg was totally manageable. Mild nausea first couple days at each new dose, nothing crazy. I was actually feeling great — down 28lbs, food noise gone, energy up.

Then I moved to 1.7mg last Tuesday and OH. MY. GOD. The nausea hit like a truck. I'm talking can't-get-off-the-couch, room-spinning, constant waves of wanting to throw up. It's been 5 days and it's barely improving.

I've tried:

  • Ginger tea/candies
  • Small bland meals
  • Staying hydrated
  • Zofran (ondansetron) 4mg — helps a little but doesn't eliminate it

Is this normal for the 1.7 jump? The jump from 0.5 to 1.0 was nothing compared to this. I'm seriously considering asking my doc to go back to 1.0. Has anyone else had this experience?

9 0LeilaHI, marcus_mpls, DeniseRN_TPA and 6 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Apr 26, 2024 at 8:57 AM#2

The 1.0 → 1.7 jump is notorious. You're going from 1.0 to 1.7 which is a 70% increase in dose. Compare that to the 0.5 → 1.0 jump which is "only" 100% — but you had less drug in your system overall. At 1.7mg you're getting into serious territory with serum levels.

It took me a solid 10-12 days to adjust to 1.7. The first week was rough but by day 10 I was back to normal. Hang in there if you can.

Some things that helped me that you didn't mention:

  • Eating protein FIRST, before any carbs or fat
  • Peppermint oil capsules (enteric coated)
  • Not lying down after eating — sit upright for at least 30 min
  • Smaller, more frequent meals — I was eating 5-6 tiny meals instead of 3
Last edited: Apr 26, 2024 at 12:57 PM
13 0tom_AK, josh_phd_bmore, roxy_nash and 10 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Apr 26, 2024 at 9:14 AM#3

e thing happened to me. I actually dropped back to 1.0 for an extra 4 weeks then tried 1.7 again and it was WAY more tolerable the second time. My endo said this is a totally reasonable approach and there's no rule that says you have to do exactly 4 weeks at each dose.

Last edited: Apr 26, 2024 at 11:14 AM
6 13tane_welly, Dr.PathRoch, mona_PHX and 3 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Apr 26, 2024 at 9:31 AM#4
Previously posted:
I'm seriously considering asking my doc to go back to 1.0. Has anyone else had this experience?

Before you step back down, a few clinical points to consider:

The 1.0 → 1.7 transition does have higher discontinuation rates in the trials. In STEP 1, the most common time for participants to drop out due to GI adverse events was during the 1.0 → 1.7 and 1.7 → 2.4 transitions.[1]

Options your prescriber might consider:

  1. Extended titration: Stay at 1.0 for 8 weeks instead of 4 before attempting 1.7 again
  2. Intermediate dosing: Some prescribers use compounded semaglutide to do a 1.25mg or 1.5mg intermediate step (note: this is off the standard Wegovy titration)
  3. Antiemetic protocol: Zofran + famotidine (Pepcid) together can be more effective than Zofran alone
  4. Dietary modifications: Strict low-fat, low-fiber diet for the first 2 weeks at the new dose

If you were doing well at 1.0 and losing weight, there's also the question of whether you even need to go to 1.7. The dose-response curve for weight loss starts to flatten at higher doses — the incremental benefit of 1.7 over 1.0 is less than the benefit of 1.0 over 0.5.

[1] Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." N Engl J Med. 2021;384(11):989-1002.
35 17sophie_paris, mel_PDX, Dr.AddMedPHL and 32 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Apr 26, 2024 at 9:48 AM#5

tbh the intermediate dosing thing saved me. I was on compounded sema and my provider did 1.0 → 1.25 → 1.5 → 1.7 with 3 weeks at each step. Barely any nausea at all. The big jumps on Wegovy are just too aggressive for some people's GI systems.

Last edited: Apr 26, 2024 at 2:48 PM
7 24BethLabQueen, ChrisMacros, KetoKyle and 4 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register